ub.xmlui.mirage2.page-structure.muninLogoub.xmlui.mirage2.page-structure.openResearchArchiveLogo
    • EnglishEnglish
    • norsknorsk
  • Velg spraaknorsk 
    • EnglishEnglish
    • norsknorsk
  • Administrasjon/UB
Vis innførsel 
  •   Hjem
  • Det helsevitenskapelige fakultet
  • Institutt for medisinsk biologi
  • Artikler, rapporter og annet (medisinsk biologi)
  • Vis innførsel
  •   Hjem
  • Det helsevitenskapelige fakultet
  • Institutt for medisinsk biologi
  • Artikler, rapporter og annet (medisinsk biologi)
  • Vis innførsel
JavaScript is disabled for your browser. Some features of this site may not work without it.

MiRNAs‐181a/b therapy in lung cancer: reality or myth?

Permanent lenke
https://hdl.handle.net/10037/17120
DOI
https://doi.org/10.1002/1878-0261.12420
Thumbnail
Åpne
article.pdf (488.5Kb)
Publisert versjon (PDF)
Dato
2019-01-03
Type
Journal article
Tidsskriftartikkel
Peer reviewed

Forfatter
Braicu, Cornelia; Gulei, Diana; Cojocneanu, Roxana Maria; Raduly, Lajos; Jurj, Ancuta; Knutsen, Erik; Calin, George Adrian; Berindan-Neagoe, Ioana
Sammendrag
Despite substantial progress in oncology, lung cancer remains the number one malignancy in terms of both incidence and mortality rates, and there thus remains an urgent need for new therapeutic alternatives. MicroRNA (miRNA) have an important role in cancer initiation and progression due to their capacity to interfere with transcriptional signaling and regulate key cellular processes. miR‐181a and miR‐181b (miR‐181a/b), which are located on chromosomes 1 and 9, are pathologically expressed in the tumor tissue and plasma of patients diagnosed with lung cancer. The miR‐181a/b regulatory mechanisms are sophisticated and are directly related to different target genes. In recent years, an ever‐increasing number of studies have focused on the biological relevance of miR‐181a/b in key cellular processes. In this paper, we aim to discuss the challenging experimental data related to miR‐181a/b and their potential use for the development of new therapeutic approaches in lung cancer. We will further present the ongoing issues regarding the regulation of their multiple target genes, and their potential use as biomarkers and therapeutic targets in this deadly malignancy.
Forlag
Wiley Open Access
Sitering
Braicu, Gulei, Cojocneanu, Raduly, Jurj, Knutsen E, Calin, Berindan-Neagoe I. MiRNAs‐181a/b therapy in lung cancer: reality or myth?. Molecular Oncology. 2019
Metadata
Vis full innførsel
Samlinger
  • Artikler, rapporter og annet (medisinsk biologi) [1105]
Copyright 2019 The Author(s)

Bla

Bla i hele MuninEnheter og samlingerForfatterlisteTittelDatoBla i denne samlingenForfatterlisteTittelDato
Logg inn

Statistikk

Antall visninger
UiT

Munin bygger på DSpace

UiT Norges Arktiske Universitet
Universitetsbiblioteket
uit.no/ub - munin@ub.uit.no

Tilgjengelighetserklæring